Pharmac announces full funding for breast cancer drug

0
11

Pharmac have announced they will fully fund the breast cancer drug palbociclib (Ibrance) for all patients with the disease.
Pfizer is the supplier of the breast cancer drug. Photo: AFP
Access for the life-extending drug will become available to all patients… [+3127 chars]Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here